rs41291963

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000289.6(PFKM):​c.594-38G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00775 in 1,593,824 control chromosomes in the GnomAD database, including 175 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 76 hom., cov: 32)
Exomes 𝑓: 0.0065 ( 99 hom. )

Consequence

PFKM
NM_000289.6 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.888

Publications

2 publications found
Variant links:
Genes affected
PFKM (HGNC:8877): (phosphofructokinase, muscle) Three phosphofructokinase isozymes exist in humans: muscle, liver and platelet. These isozymes function as subunits of the mammalian tetramer phosphofructokinase, which catalyzes the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate. Tetramer composition varies depending on tissue type. This gene encodes the muscle-type isozyme. Mutations in this gene have been associated with glycogen storage disease type VII, also known as Tarui disease. Alternatively spliced transcript variants have been described.[provided by RefSeq, Nov 2009]
PFKM Gene-Disease associations (from GenCC):
  • glycogen storage disease VII
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, PanelApp Australia, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 12-48134194-G-A is Benign according to our data. Variant chr12-48134194-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 255764.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0194 (2950/152282) while in subpopulation AFR AF = 0.0484 (2012/41546). AF 95% confidence interval is 0.0467. There are 76 homozygotes in GnomAd4. There are 1498 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 76 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PFKMNM_000289.6 linkc.594-38G>A intron_variant Intron 6 of 22 ENST00000359794.11 NP_000280.1 P08237-1A0A024R0Y5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PFKMENST00000359794.11 linkc.594-38G>A intron_variant Intron 6 of 22 1 NM_000289.6 ENSP00000352842.5 P08237-1

Frequencies

GnomAD3 genomes
AF:
0.0192
AC:
2915
AN:
152164
Hom.:
70
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0478
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.00956
Gnomad ASJ
AF:
0.0325
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.0299
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.00450
Gnomad OTH
AF:
0.0129
GnomAD2 exomes
AF:
0.0109
AC:
2739
AN:
251464
AF XY:
0.00982
show subpopulations
Gnomad AFR exome
AF:
0.0498
Gnomad AMR exome
AF:
0.00480
Gnomad ASJ exome
AF:
0.0337
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0275
Gnomad NFE exome
AF:
0.00541
Gnomad OTH exome
AF:
0.0111
GnomAD4 exome
AF:
0.00652
AC:
9400
AN:
1441542
Hom.:
99
Cov.:
29
AF XY:
0.00641
AC XY:
4603
AN XY:
718554
show subpopulations
African (AFR)
AF:
0.0479
AC:
1586
AN:
33078
American (AMR)
AF:
0.00488
AC:
218
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.0345
AC:
896
AN:
26008
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39592
South Asian (SAS)
AF:
0.00471
AC:
405
AN:
85906
European-Finnish (FIN)
AF:
0.0283
AC:
1512
AN:
53416
Middle Eastern (MID)
AF:
0.0233
AC:
134
AN:
5748
European-Non Finnish (NFE)
AF:
0.00365
AC:
3992
AN:
1093484
Other (OTH)
AF:
0.0110
AC:
656
AN:
59612
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
512
1024
1536
2048
2560
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0194
AC:
2950
AN:
152282
Hom.:
76
Cov.:
32
AF XY:
0.0201
AC XY:
1498
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.0484
AC:
2012
AN:
41546
American (AMR)
AF:
0.00954
AC:
146
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0325
AC:
113
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00248
AC:
12
AN:
4830
European-Finnish (FIN)
AF:
0.0299
AC:
317
AN:
10618
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.00450
AC:
306
AN:
68014
Other (OTH)
AF:
0.0128
AC:
27
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
132
264
396
528
660
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0151
Hom.:
5
Bravo
AF:
0.0196
Asia WGS
AF:
0.00953
AC:
33
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 16, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
2.5
DANN
Benign
0.41
PhyloP100
-0.89
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41291963; hg19: chr12-48527977; API